Table 1.
Participant baseline data.
| Index | LZJ | AT | CN |
|---|---|---|---|
| (N = 21) | (N = 20) | (N = 15) | |
| Females (%) | 71% | 65% | 87% |
| Age (years) | 65.19 ± 6.48 | 60.7 ± 8.03 | 52.93 ± 8.87 |
| BMI (kg/m2) | 23.88 ± 2.44 | 24.84 ± 2.53 | 21.79 ± 2.09 |
| SBP (mmHg) | 153.81 ± 16.57 | 144.85 ± 18.20 | 119.13 ± 8.85 |
| DBP (mmHg) | 85.19 ± 12.15 | 88.9 ± 10.33 | 77.27 ± 10.75 |
| HR (BPM) | 76.00 ± 12.43 | 70.05 ± 10.49 | 67.44 ± 11.40 |
| 24 h ABPM | |||
| SBP (mmHg) | 142.57 ± 16.18 | 130.6 ± 14.75 | 112.73 ± 8.45 |
| DBP (mmHg) | 82.52 ± 9.11 | 84.55 ± 11.90 | 67.47 ± 7.09 |
| Day-time ABPM | |||
| SBP (mmHg) | 143.71 ± 17.13 | 132.15 ± 16.04 | 113.2 ± 7.97 |
| DBP (mmHg) | 85.76 ± 10.87 | 87.05 ± 13.44 | 67.8 ± 7 |
| Night-time ABPM | |||
| SBP (mmHg) | 140.67 ± 18.47 | 127 ± 16.14 | 109.07 ± 13.58 |
| DBP (mmHg) | 77.95 ± 8.88 | 79.55 ± 11.51 | 65.8 ± 9.14 |
| ET-1 (pg/mL) | 9.31 ± 10.39 | 9.88 ± 12.61 | 8.48 ± 12.75 |
| NO (pg/mL) | 3.81 ± 5.82 | 2.32 ± 0.87 | 2.99 ± 0.45 |
| MMP-9 (pg/mL) | 3,639.94 ± 2,690.04 | 4,382.04 ± 2,767.32 | 1,429.51 ± 1,707.32 |
| IL-6 (pg/mL) | 4.00 ± 2.10 | 2.99 ± 1.17 | 2.554 ± 0.81 |
| IL-10 (pg/mL) | 4.81 ± 2.85 | 7.016 ± 9.12 | 6.438 ± 4.75 |
| Calcium channel blocker(%) | 95% | 85% | 0 |
| Not taking antihypertensive drug(%) | 5% | 15% | 100% |